Novo Nordisk A S (NVO) earnings: date, estimates and history
Price $41.72 · data as of November 16, 2026
Next earnings report
The date appears here once Novo Nordisk A S confirms it, usually two to four weeks before the report.
Track record
Novo Nordisk A S beat the consensus earnings estimate in 4 of its last 5 reports, by +10.6% on average. On report days the stock moved 5.0% on average, up or down.
Earnings history
| Reported | EPS estimate | EPS actual | Surprise | Revenue | Revenue growth | Stock move |
|---|---|---|---|---|---|---|
| November 4, 2026 Sep/2026 | $4.62 | $5.79 | +25.3% | — | — | +0.3% |
| August 4, 2026 Jun/2026 | $4.98 | $6.18 | +24.0% | — | — | −5.4% |
| May 6, 2026 Mar/2026 | $6.96 | $6.63 | −4.8% | — | — | +2.1% |
| February 4, 2026 Dec/2025 | $5.90 | $6.04 | +2.3% | — | — | −13.8% |
| November 5, 2025 Sep/2025 | $4.24 | $4.50 | +6.0% | — | — | −3.6% |
EPS as compared with analyst estimates (adjusted EPS). Revenue growth is against the same quarter a year earlier. Stock move: change on the first trading day after the report.
Frequently asked questions
When is Novo Nordisk A S’s next earnings date?
Novo Nordisk A S has not confirmed its next report date yet. Its last report was on November 4, 2026.
Did Novo Nordisk A S beat earnings last quarter?
Yes, it reported EPS of $5.79 on November 4, 2026 against an estimate of $4.62 (a +25.3% surprise), and the stock moved +0.3% the next trading day.
Report dates and estimates from analyst consensus data; results from company reports. Updated daily. Not investment advice. Earnings calendar